International immunopharmacology
-
Int. Immunopharmacol. · Dec 2015
Review Meta AnalysisUlinastatin- and thymosin α1-based immunomodulatory strategy for sepsis: A meta-analysis.
This meta-analysis was performed to evaluate the efficacy of ulinastatin (UTI) and thymosin α1 (Tα1) based immunomodulatory strategy in sepsis patients. ⋯ Immunomodulatory therapy that combines ulinastatin and Tα1 significantly improves all-cause mortality, inflammatory mediators and duration of mechanical ventilation in subjects with sepsis.